Skip to main content

Asset Dedication, LLC

SEC CIK
0001475896
Latest filing
Jul 30, 2026

INMB holding history

Inmune Bio, Inc. in every 13F filed by Asset Dedication, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INMB overviewAll 13F holders of INMBFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q1 2021
Holdings of INMB by Asset Dedication, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−814−100.0%Sold outHolders
Q3 2023814$6.00K<0.1%00.0%UnchangedHolders
Q2 2023814$7.00K<0.1%00.0%UnchangedHolders
Q1 2023814$5.00K<0.1%00.0%UnchangedHolders
Q4 2022814$5.00K<0.1%00.0%UnchangedHolders
Q3 2022814$5.00K<0.1%00.0%UnchangedHolders
Q2 2022814$7.00K<0.1%00.0%UnchangedHolders
Q1 2022814$7.00K<0.1%00.0%UnchangedHolders
Q4 2021814$8.00K<0.1%00.0%UnchangedHolders
Q3 2021814$16.0K<0.1%00.0%UnchangedHolders
Q2 2021814$14.0K<0.1%00.0%UnchangedHolders
Q1 2021814$10.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.